To analyze the effects of HPV16 E6 variants on cell phenotype and p53 degradation, we constructed plasmids of the E6 wild type (NP_041325.1) and E6 variants (D32E and H85Y) and expressed them in HPV-negative cervical cancer cell line. This evidence concerns the gene TP53 and cervical cancer.